PAR3 Recombinant antibody

PAR3 Uni-rAbTM Recombinant Antibody for WB, ELISA
Cat No. 84593-1-RR

产品说明书

CloneNo. 241780F7

宿主/亚型

Rabbit / IgG

种属反应性

human, mouse, rat

应用

WB, ELISA

F2RL2, Proteinase-activated receptor 3, PAR-3, PAR 3, Coagulation factor II receptor-like 2

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inMDCK cells, NIH/3T3 cells, RAW 264.7 cells, rat brain tissue

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:5000-1:50000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

84593-1-RR targets PAR3 in WB, ELISA applications and shows reactivity with human, mouse, rat samples.

经测试应用 WB, ELISA Application Description
经测试反应性 human, mouse, rat
免疫原 Peptide 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 coagulation factor II (thrombin) receptor-like 2
别名 F2RL2, Proteinase-activated receptor 3, PAR-3, PAR 3, Coagulation factor II receptor-like 2
计算分子量 374 aa, 43 kDa
观测分子量45 kDa
GenBank蛋白编号BC093648
基因名称 PAR3
Gene ID (NCBI) 2151
RRIDAB_3672089
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purfication
UNIPROT IDO00254
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

PAR3 is a crucial protein involved in the establishment and maintenance of cell polarity across various species. It plays a significant role in organizing cellular structures and functions, particularly in epithelial and neuronal cells. PAR3 has been implicated in various aspects of cancer biology. It can act as a tumor suppressor in epithelial cancers, and its expression or mutations have been associated with the progression and behavior of glioblastoma, pancreatic cancer, and other malignancies.

实验方案

Product Specific Protocols
WB protocol for PAR3 antibody 84593-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...